Value-Based Cancer Care Issues

December 2015, Vol 6, No 11

Oncology News – December 2015

Oncology News

  • ASH's 5 New Choosing Wisely Recommendations for Hematologists
  • Advances in Multiple Myeloma Generate Excitement at ASH 2015
  • First Precision Medicine Trial in Cancer Prevention Identifies Patients for Chemoprevention
[ Read More ]

ASCO/AAHPM Guidance Statement Could Standardize Palliative Care in Oncology

Meg Barbor, MPH

Clinical Guidelines

Boston, MA—A new guidance statement from the American Society of Clinical Oncology (ASCO) and the American Academy of Hospice and Palliative Medicine (AAHPM) provides the first formal, consensus-based recommendations regarding high-quality primary palliative care in oncology, according to Kathleen E. Bickel, MD, MPhil, Assistant Professor of Medicine, Geisel School of Medicine at Dartmouth, Hanover, NH. [ Read More ]

Addressing Fertility Issues in Patients with Breast Cancer

Chase Doyle


Fertility and early menopause after cancer can pose challenging emotional and medical issues for patients and their clinicians. Survivors who become infertile because of their cancer treatment are at an increased risk for emotional distress and are often affected by unresolved grief and depression, according to Ann H. Partridge, MD, MPH, Medical Oncologist, Dana-Farber Cancer Institute, Boston. [ Read More ]

Treating Sexual Dysfunction in Breast Cancer Survivors

Chase Doyle


Sexual dysfunction is prevalent in women with breast cancer, a consequence of treatment that affects pre- and postmenopausal women. However, the safety and efficacy of available treatments remain understudied, according to Shari B. Goldfarb, MD, Medical Oncologist, Breast Medicine Service, Memorial Sloan Kettering Cancer Center (MSKCC), NY. [ Read More ]

Getting to Value-Based Cancer Care in the ’Omics Era Requires Data Integration

Wayne Kuznar

AVBCC 2015 5th Annual Conference

Washington, DC-An evolving knowledge of cancer biology and the availability of comprehensive genetic testing engender a need for tools that help oncologists integrate these data and select therapy, said Gary Palmer, MD, Chief Medical Officer, NantHealth, Los Angeles, CA, in delivering his keynote address at the Fifth Annual Conference of the Association for Value-Based Cancer Care. [ Read More ]

FDA News – December 2015

FDA Approvals, News & Updates

  • Darzalex First Monoclonal Antibody Approved by the FDA for Multiple Myeloma
  • Ninlaro First Oral Proteasome Inhibitor Approved for Multiple Myeloma
  • Empliciti Second Monoclonal Antibody Approved by the FDA for Multiple Myeloma
  • Cotellic Approved for Patients with Advanced Melanoma
  • Portrazza Receives FDA Approval for Metastatic Squamous NSCLC
  • FDA Approved Tagrisso for Patients with NSCLC and EGFR Mutation, Together with a Companion Diagnostic Test
[ Read More ]